KRISTINA REID: Open Payments
NPI 1215473087 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,524 in 121 payments from 29 companies in 2025. Trend: 2023 $1,076 · 2024 $946 · 2025 $2,524
Food & beverage: $2,524
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $726 |
| PFIZER INC. | 15 | $287 |
| ARGENX US, INC. | 7 | $162 |
| Biogen, Inc. | 5 | $108 |
| CSL Behring | 4 | $104 |
| Lilly USA, LLC | 5 | $104 |
| UCB, Inc. | 3 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $93 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| Celgene Corporation | 3 | $71 |
Products named: NURTEC ODT, UBRELVY, BOTOX, QULIPTA, VYVGART HYTRULO, Hizentra, HYQVIA, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
